Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death

被引:35
|
作者
Carroll, Sandra L. [1 ]
Strachan, Patricia H. [1 ]
de Laat, Sonya [1 ]
Schwartz, Lisa [2 ]
Arthur, Heather M. [3 ]
机构
[1] McMaster Univ, Sch Nursing, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Arnold L Johnson Chair Hlth Care Eth, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Michael G DeGroote Endowed Chair Cardiovasc Nursi, Heart & Stroke Fdn Ontario, Sch Nursing, Hamilton, ON L8S 4K1, Canada
基金
加拿大健康研究院;
关键词
cardiovascular; implantable defibrillator; patient decision making; patient values; primary prevention; sudden cardiac death; SURVIVAL;
D O I
10.1111/j.1369-7625.2011.00703.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Patients are offered implantable defibrillators (ICDs) for the prevention of sudden cardiac death (SCD). However, patients' decision-making process (DMP) of whether or not to accept an ICD has not been explored. We asked patients about their decision making when offered an ICD. Design/Setting A grounded theory methodology was employed. Patients were recruited from three ICD centres. Those who received an ICD underwent interviews the first month after implant. Declining patients had interviews at their convenience. In-depth analysis of transcripts was completed. Identified themes were placed along process pathways in a DMP model and tested. Findings Forty-four patients consented to participate (25% women). Thirty-four accepted an ICD and 10 (23%) declined. Ages ranged from 26 to 87 (mean=65; SD=12.5). Participants were retired (65%), had ischaemic heart disease (64%) and some post-secondary education (52%). The DMP was triggered when patient's risk for SCD was communicated. The physician's recommendation and a new awareness SCD risk were motivators to accept the ICD. Patient's decision-making approaches fell along a continuum, from active and engaged to passive and indifferent. Patient's approaches were influenced most by the following: (i) trust; (ii) social influences and (iii) health state. Conclusions Health-care providers need to recognize the DMP pathways in which ICD candidacy and SCD risk are understood. The factors that influence a patient's decision warrant discussion pre-implant. It is imperative that patients comprehend the meaning of ICD candidacy to make an informed decision. Participants did not recall alternatives to receiving ICD therapy.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 50 条
  • [21] Racial Variation in Implantable Cardioverter Defibrillator Placement for the Primary Prevention of Sudden Cardiac Death in Veterans
    Mohn, James N.
    Richardson, Kelly K.
    Vaughan-Sarrazin, Mary S.
    Cram, Peter M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A133 - A133
  • [22] Incidence of arrhythmic events in patients with implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death
    Capoferri, M
    Schwick, N
    Tanner, H
    Fuhrer, J
    Delacretaz, E
    SWISS MEDICAL WEEKLY, 2004, 134 (11-12) : 154 - 158
  • [23] Implantable Cardioverter Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death is Effective in Patients with Chronic Kidney Disease
    Naksuk, Niyada
    Herzog, Charles
    Benditt, David
    Ko, Byungsoo
    Tholakanahalli, Venkat
    Li, Jian-Ming
    Adabag, Selcuk
    CIRCULATION, 2012, 126 (21)
  • [24] Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy
    Cardinalli-Neto, Augusto
    Nakazone, Marcelo A.
    Grassi, Luciano V.
    Tavares, Bruno G.
    Bestetti, Reinaldo B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 94 - 95
  • [25] Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator
    Carmen Adduci
    Francesca Palano
    Giacomo Silvetti
    Pietro Cosentino
    Pietro Francia
    High Blood Pressure & Cardiovascular Prevention, 2020, 27 : 291 - 297
  • [26] Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator
    Adduci, Carmen
    Palano, Francesca
    Silvetti, Giacomo
    Cosentino, Pietro
    Francia, Pietro
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2020, 27 (04) : 291 - 297
  • [27] SUDDEN CARDIAC DEATH PREVENTION - ANTIARRHYTHMIC DRUGS AND THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    DOMANSKI, MJ
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1995, 8 (01) : 9 - 15
  • [28] Implantable Cardioverter Defibrillator Therapy for Prevention of Sudden Cardiac Death in Children in The Netherlands
    Heersche, Jogien H. M.
    Blom, Nico A.
    Van De Heuvel, Freek
    Blank, Christiaan
    Reimer, Annette G.
    Clur, Sally-Ann
    Witsenburg, Maarten
    Ten Harkel, A. Derk Jan
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (02): : 179 - 185
  • [29] IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR PRIMARY PREVENTION OF SUDDEN DEATH IS EFFECTIVE IN OCTOGENARIANS
    Naksuk, Niyada
    Benditt, David
    Tholakanahalli, Venkat
    Li, Jian-Ming
    Adabag, Selcuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E394 - E394
  • [30] Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap
    Estes, N. A. Mark
    Saba, Samir
    EUROPEAN HEART JOURNAL, 2020, 41 (36) : 3448 - 3450